Abstract
Doxorubicin is an anticancer drug known for a variety of cancers. As a targeted drug, it is loaded onto branched graphene oxide nanoparticles (GONPs). In this research, polymeric coatings containing vinyl alcohol bonded of the fifth generation of dendrimers containing methyl methacrylate (MMA) and ethylenediamine (EDA) groups act as a responsive polymer. The precursors are polymerized to form the dendrimer coating as the last carrier on the graphene oxide surface. Then polyvinyl alcohol (pH-sensitive polymer) coating is used on the surface of branched graphene oxide. When the nanoparticles carry the drug, they are not recognized by the immune system. The amount of drug release is increased. The average size of the final product is 30 nm. It is characterized by FTIR, TGA, XRD, and SEM-EDX to investigate different adsorption properties. Some of the physical parameters of the adsorption process, such as pH, time, and temperature for doxorubicin are investigated using the final adsorbent. The drug release by the adsorbent coated with pH-sensitive polymer is more than when the polymer coating was not applied on the nanoparticle. Drug release tests showed pH sensitivity behavior of graphene oxide/dendrimer/polyvinyl alcohol (GO/dendrimer/PVA), with %99.7 drug release at acidic (pH = 5.6) and %59 at neutral (pH = 7.4) conditions, that's means in the pH of a tumorous cell and the blood pH level, respectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
